The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities

Advances in Experimental Medicine and Biology

Volumn 686, Issue , 2010, Pages 433-453

  Schendel, Diana ^a   Rice, Catherine ^b   Cunniff, Christopher ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NONE

Author keywords

22q11.2 deletion syndrome; Autism spectrum disorders; Epidemiology; Fragile X syndrome; Intellectual disability; Neurodevelopmental disabilities; Rare disorders

Indexed keywords

ARTICLE; AUTISM; CHROMOSOME DELETION 22Q11; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; FRAGILE X SYNDROME; GENETIC DISORDER; GENETIC RISK; HUMAN; INTELLECTUAL IMPAIRMENT; NEURODEVELOPMENTAL DISABILITY; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT; RISK FACTOR; CHILD; CHROMOSOME 22; CHROMOSOME DELETION; CLASSIFICATION; FEMALE; MALE; MENTAL DEFICIENCY; PHENOTYPE; PRESCHOOL CHILD; REVIEW;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DEVELOPMENTAL DISABILITIES; FEMALE; FRAGILE X SYNDROME; HUMANS; MALE; MENTAL RETARDATION; PHENOTYPE; RARE DISEASES;

EID: 79952045099     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-9485-8_24     Document Type: Article

References (63)

1. http://www.aaidd.org/content-104.cfm
2. Abrahams BS, Geschwind DH (2008) Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9(5):341-355 (Pubitemid 351556064)
3. Antshel K, Fremont W, Kates WR (2008) The neurocognitive phenotype in Velo-Cardio-Facial syndrome: A developmental perspective. Dev Disabil Res Rev 14:43-51 (Pubitemid 351716522)
4. Bailey DB Jr, Raspa M, Olmsted M, Holiday DB (2008) Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. Am J Med Genet A 146A:2060-2069
5. Bhasin TK, Brocksen S, Avchen RN, Van Naarden Braun K (2006) Prevalence of four developmental disabilities among children aged 8 years -Metropolitan Atlanta Developmental Disabilites Surveillance Program, 1996 and 2000. MMWR Surveill Summ 55(SS-01):1-9
6. Botto LK, May K, Fernhoff PM, et al (2003) A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution of major birth defects in the population. Pediatrics 112:101-107 (Pubitemid 36792936)
7. Boulet SL, Boyle CA, Schieve LA (2009) Health care use and health and functional impact of developmental disabilities among US children, 1997-2005. Arch Pediatr Adolesc Med 163(1):19-26
8. Boyle CA, Decouflé P, Yeargin-Allsopp M (1994) Prevalence and health impact of developmental disabilities in US children. Pediatrics 93(3):399-403 (Pubitemid 24067011)
9. Centers for Disease Control and Prevention (2007) Prevalence of autism spectrum disorders -autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56(1):12-28
10. Centers for Disease Control and Prevention (in press) Update on the prevalence of autism spectrum disorders -autism and developmental disabilities monitoring network, 11 sites, United States, 2006. MMWR Surveill Summ
11. Centers for Disease Control and Prevention (in press) Update on the prevalence of autism spectrum disorders -autism and developmental disabilities monitoring network, 11 sites, United States, 2006. MMWR Surveill Summ 11. Coffee B, Krayton K, Albizua I, et al (2009) Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 85:503-514
12. Cohen D, Pichard N, Tordjman S, et al (2005) Specific genetic disorders and autism: Clinical contribution towards their identification. J Autism Dev Disord 35(1):103-116 (Pubitemid 40883082)
13. Constantino JN, Todd RD (2003) Autistic traits in the general population: A twin study. Arch Gen Psychiatry 60(5):524-530 (Pubitemid 36539062)
14. Crawford DC, Meadows KL, Newman JL, et al (2002) Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet A 110:226-233 (Pubitemid 34627626)
15. Croen LA, Grether JK, Selvin S (2001) The epidemiology of mental retardation of unknown cause. Pediatrics 107:E86
16. Devriendt K, Fryns JP, Mortier G, van ThienenMN, Keymolen K (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:789-790
17. de Vries BB, van den Ouweland AM, Mohkamsing S, et al (1997) Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet 61:660-667 (Pubitemid 27418408)
18. Drews CD, Yeargin-Allsopp M, Decoufle P, et al (1995) Variation in the influence of selected sociodemographic risk factors for mental retardation. Am J Public Health 85:329-334
19. Dykens EM (2000) Annotation: Psychopathology in children with intellectual disability. J Child Psychol Psychiatr 41:407-417 (Pubitemid 30311519)
20. Filipek P, Accardo PJ, Ashwal S, et al (2000) Practice parameter: Screening and diagnosis of autism. Report of the quality standards subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55:468-479
21. Fombonne E (2003) Epidemiological surveys of autism and other pervasive developmental disorders: An update. J Autism Dev Disord 33(4):365-82 (Pubitemid 37127933)
22. Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65(6):591-598
23. Gillberg C, Coleman M (2000) The biology of the autistic syndromes, 3rd edn. Mac Keith Press, UK
24. Goodship J, Cross I, LiLing J, Wren C (1998) A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79:348-351 (Pubitemid 28436089)
25. Hatton DD, Sideris J, Skinner M, et al (2006) Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. Am J Med Genet A 140:1804-1813 (Pubitemid 44330644)
26. Inlow JK, Restifo LL (2004). Molecular and comparative genetics of mental retardation. Genetics 166:835-881 (Pubitemid 38391747)
27. Johnson CP, Myers S, American Academy of Pediatrics Council on ChildrenWith Disabilities (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120(5):1183-215 (Pubitemid 350085561)
28. Larsson H, Eaton W, Madsen K, et al (2005) Risk factors for autism: Perinatal factors, parental psychiatric history and socioeconomic status. Am J Epidemiol 161: 916-925 (Pubitemid 40656413)
29. Leonard H, Petterson B, Bower C, Sanders R (2003) Prevalence of intellectual disability in Western Australia. Paediatr Perinat Epidemiol 17:58-67 (Pubitemid 37128710)
30. Leonard H, Wen X (2002) The epidemiology of mental retardation: Challenges and opportunities in the new millennium. MRDD Res Rev 8:117-134 (Pubitemid 36378154)
31. Martin CL, Ledbetter DH (2007) Autism and cytogenetic abnormalities: Solving autism one chromosome at a time. Curr Psychiatry Rep 9(2):141-147 (Pubitemid 46579152)
32. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al (2001) Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! Genet Med 3:23-29
33. Moeschler JB (2008) Medical genetics diagnostic evaluation of the child with global developmental delay or intellectual disability. Curr Opin Neurol 21:117-122 (Pubitemid 351644150)
34. Moro F, Pisano T, Bernardina BD, et al (2006) Periventricular heterotopia in fragile X syndrome. Neurology 67: 713-715 (Pubitemid 44273630)
35. Moss EM, Batshaw ML, Solot CB, et al (1999) Psychoeducational prole of the 22q11.2 microdeletion: A complex pattern. J Pediatr 134:193-198 (Pubitemid 29089044)
36. Moss J, Howlin P (2009) Autism spectrum disorders in genetic syndromes: Implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intellect Disabil Res 53(10):852-873
37. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velocardio-facial syndrome. Arch Gen Psychiatry 56:940-945 (Pubitemid 29480131)
38. Newschaffer CJ, Croen LA, Daniels J, et al (2007) The epidemiology of autism spectrum disorders. Annu Rev Public Health. 28:235-58 (Pubitemid 46833342)
39. Nordin V, Gillberg C (1998) The long-term course of autistic disorders: Update on follow-up studies. Acta Psychiatr Scand 97(2):99-108 (Pubitemid 28145453)
40. Posserud MB, Lundervold AJ, Gillberg C (2006). Autistic features in a total population of 7-9-year-old children assessed by the ASSQ (Autism Spectrum Screening Questionnaire). J Child Psychol Psychiatr 47(2):167-175
41. Rare Diseases Task Force Report to the European Commission High Level Group on Health Care (2005) Overview of Current Centres of Reference on rare diseases in the EU. http://ec.europa.eu/health/ph-threats/non-com/rare-8-en. print.htm
42. Rauch A, Hoyer J, Guth S, et al (2006) Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A 140:2063-2074 (Pubitemid 44522453)
43. Ropers HH (2007) New perspectives for the elucidation of genetic disorders. Am J Hum Genet 81:199-207
44. Rutter M, Silberg J, O'Connor T, Simonoff E (1999) Genetics and child psychiatry: II Empirical research findings. J Child Psychol Psychiatr 40(1):19-55 (Pubitemid 29051936)
45. Schaefer GB, Lutz RE (2006) Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med 8:549-556 (Pubitemid 44402031)
46. Schaefer GB, Mendelsohn NJ (2008) Clinical genetics evaluation in identifying the etiology of the autism spectrum disorders. Genet Med 10: 301-305 (Pubitemid 351544133)
47. Schalock RL, Luckasson RA, Karrie A, et al (2007) The renaming of mental retardation: Understanding the change to the term intellectual disability. Intellect Dev Disabil 45:116-124
48. Schopler E, Andrews CE, Strupp K (1979) Do autistic children come from upper-middle class parents? J Autism Dev Disord 9:139-152 (Pubitemid 10103646)
49. Shevell MI, Majnamer A, Rosenbaum P, Abrahamowicz M (2001) Etiologic yield of autism spectrum disorders: A prospective study. J Child Neurol 16:509-512 (Pubitemid 32725387)
50. Shevell M, Ashwal S, Donley D et al (2003) Practice parameter: Evaluation of the child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 60 (3): 367-380 (Pubitemid 36188229)
51. ShevellM(2008) Global developmental delay and mental retardation or intellectual disability: Conceptualization, evaluation, and etiology. Pediatr Clin North Am 55:1071-1084
52. Skuse D. (2007) Rethinking the nature of genetic vulnerability to autism spectrum disorders. Trends Genet 23: 387-395 (Pubitemid 47088014)
53. Solot CB, Gerdes M, Kirschner RE, et al (2001) Communication issues in 22q11.2 deletion syndrome: Children at risk. Genet Med 3:67-71
54. Srour M, Mazer B, Shevell MI (2006) Analysis of clinical features predicting etiologic yield in the assessment of global developmental delay. Pediatrics 118:139-145 (Pubitemid 46074631)
55. Tarleton JC, Saul RA (1993) Molecular genetic advances in fragile X syndrome. J Pediatr 122:169-185 (Pubitemid 23041542)
56. Van Karnebeek CDM, JansweijerMCE, Leenders AGE, et al (2005) Diagnostic investigations in individuals with mental retardation: A systematic literature review of their usefulness. Eur J Hum Genet 13: 6-25
57. Van Naarden Braun K, Yeargin-Allsopp M (2008) Epidemiology of intellectual disabilities. In: Levene MI, Chervenak FA (eds) Fetal and neonatal neurology and neurosurgery. Elsevier, London
58. Wing L (1980) Childhood autism and social class: A question of selection. Br J Psychiatr 137: 410-417 (Pubitemid 10030104)
59. Yeargin-Allsopp M, Drews CD, Decoufle P, et al (1995). Mild mental retardation in black and white children in metropolitan Atlanta: A case-control study. Am J Public Health 85: 324-328
60. Yeargin-Allsopp M, Boyle C (2002) Overview: The epidemiology of neurodevelopmental disorders. Ment Retard Dev Disabil Res Rev 8:113-116 (Pubitemid 36378153)
61. Yeargin-Allsopp M, Rice C, Karapurkar T, et al (2003) Prevalence of autism in a US metropolitan area. JAMA 289: 49-55 (Pubitemid 36026277)
62. 62, Zahir F, Friedman JM(2007) The impact of array genomic hybridization on mental retardation research: A review of current technologies and their clinical utility. Clin Genet 72: 271-287 (Pubitemid 47394217)
63. Zecavati N, Spence SJ (2009) Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep 9(2):129-136